Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Search
Sign in
Sign up
PTP
PHAS
Platform Technology Partners’s
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
Stock Holding History
Platform Technology Partners’s Portfolio
PHAS Stock Details
PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter
Market Value
Status
Shares
Change in
Stake
Trade Value
Portfolio Weight
Portfolio Position
2022
Q4
–
Sell
2022
Q3
$41K
Sell
2022
Q2
$146K
Buy
2022
Q1
$320K
Sell
2021
Q4
$657K
Buy
2021
Q3
$713K
Sell
2021
Q2
$853K
Buy
2020
Q4
$474K
Buy
2020
Q3
$326K
Buy
2020
Q2
$248K
Buy
2020
Q1
$115K
Buy
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Theme
Close